Brief: Spectral Ai Receives FDA De Novo Clearance For Deepview® System For Burn Indication
26/05/2026 12:10
May 26 (Reuters) - Spectral AI Inc MDAI.O: SPECTRAL AI RECEIVES FDA DE NOVO CLEARANCE FOR DEEPVIEW® SYSTEM FOR BURN INDICATION SPECTRAL AI INC - AUTHORIZED TO COMMENCE COMMERCIAL DISTRIBUTION IN THE UNITED STATES Source text: ID:nGNX72BsKy Further company coverage: MDAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral AI
See all newsBrief: Spectral Ai Receives FDA De Novo Clearance For Deepview® System For Burn Indication
Brief: Spectral Ai Inc - Forecasts Fy2026 Revenue Of About $18.5 Million
Brief: Spectral Ai Names David Mcguire, Cpa, As Chief Financial Officer
Brief: Spectral Ai Names Vincent S. Capone As Chief Executive Officer
Brief: Spectral AI raises $7.6 Million of Additional Growth Capital